OGEN Oragenics Inc

Price (delayed)

$0.588

Market cap

$2.65M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.97

Enterprise value

-$3.4M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

Oragenics, Inc. is focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic and the further development of effective treatments for novel antibiotics against ...

Highlights
The debt has dropped by 98% year-on-year and by 75% since the previous quarter
Oragenics's net income has increased by 4.9% YoY
OGEN's EPS has dropped by 121% year-on-year and by 9% since the previous quarter
Oragenics's equity has decreased by 25% from the previous quarter

Key stats

What are the main financial stats of OGEN

OGEN stock price

How has the Oragenics stock price performed over time
Intraday
1.73%
1 week
-3.7%
1 month
-1.51%
1 year
-83.48%
YTD
-24.92%
QTD
4.98%

Financial performance

How have Oragenics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.59M
Net income
-$9.83M
Gross margin
N/A
Net margin
N/A
OGEN's operating income is up by 5% year-on-year but it is down by 2.5% since the previous quarter
Oragenics's net income has increased by 4.9% YoY

Price vs fundamentals

How does OGEN's price correlate with its fundamentals

Growth

What is Oragenics's growth rate over time

Valuation

What is Oragenics stock price valuation
P/E
N/A
P/B
0.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OGEN's EPS has dropped by 121% year-on-year and by 9% since the previous quarter
The P/B is 88% less than the 5-year quarterly average of 3.4
Oragenics's equity has decreased by 25% from the previous quarter

Efficiency

How efficient is Oragenics business performance
OGEN's ROE has soared by 81% YoY and by 27% from the previous quarter
OGEN's ROA has soared by 61% year-on-year and by 11% since the previous quarter
The company's return on invested capital rose by 43% QoQ

Dividends

What is OGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OGEN.

Financial health

How did Oragenics financials performed over time
The total assets has soared by 94% YoY but it has contracted by 26% from the previous quarter
The total liabilities has plunged by 65% YoY and by 27% from the previous quarter
The debt is 99% smaller than the equity
OGEN's debt to equity has shrunk by 100% YoY and by 67% QoQ
The debt has dropped by 98% year-on-year and by 75% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.